Topical propranolol therapy for infantile hemangiomas

Pediatric Dermatology

Volumn 29, Issue 2, 2012, Pages 154-159

  Kunzi Rapp, Karin ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; MALE; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN INDURATION; SKIN IRRITATION; TREATMENT RESPONSE; TUMOR REGRESSION; ULCER HEALING; WHEEZING;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; INFANT; LASER THERAPY; MALE; OINTMENTS; PROPRANOLOL; SKIN NEOPLASMS; SKIN ULCER; TREATMENT OUTCOME;

EID: 84859108637     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01615.x     Document Type: Article

References (23)

1. Léauté-LabrÈze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
2. Schiestl C, Neuhaus K, Zoller S, et al., Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr 2011; 17: 439-501.
3. Sans V, Dumas de la Roque E, Berge J, et al., Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: 423-431.
4. Manunza F, Syed S, Laguda B, et al., Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162: 452-468.
5. Maguiness SM, Frieden IJ,. Current management of infantile hemangiomas. Sem Cutan Med Surg 2010; 29: 106-114.
6. Zimmermann AP, Wiegand S, Werner JA, et al., Propranolol therapy for infantile haemangiomas: review of literature. Int J Pediatr Otorhinolaryngol 2010; 74: 338-342.
7. Hermans DJJ, Van Beynum IM, Schultze Kool LJ, et al., Propranolol, a very promising treatment for ulceration in infantile hemangiomas; a study of 20 cases with matched historical controls. J Am Acad Dermatol 2011; 64: 833-838.
8. Saint-Jean M, Léauté-LabrÈze C, Mazereeuw-Hautier J, et al., Propranolol for the treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol 2011; 64: 827-832.
9. Bagazgoitia L, Torrelo A, Lõpez Gutiérrez JC, et al., Propranolol for infantile hemangiomas. Pediatr Dermatol 2011; 28: 108-114.
10. Léauté-LabrÈze C, Prey S, Ezzedine K,. Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011, May 14. [Epub ahead of print] DOI
11. Bonifazi E, Colonna V, Mazzotta F, et al., Propranolol in rapidly growing hemangiomas. Eur J Pediat Dermatol 2008; 18: 185-192.
12. Ranchod TM, Frieden IJ, Fredrick DR,. Corticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence. Br J Ophthalmol 2005; 89: 1134-1138.
13. Ho NTC, Lansang P, Pope E,. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007; 56: 63-68.
14. McCuaig CC, Dubois J, Powell J, et al., A phase II, open labelled study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 2009; 26: 203-212.
15. Guo S, Ni N,. Topical treatment for capillary hemangioma of the eyelid using blocker solution. Arch Ophthalmol 2010; 128: 255-256.
16. Pope E, Chakkittakandiyil A,. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-565.
17. Ni N, Langer P, Wagner R, et al., Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol 2011; 129: 377-379.
18. Zvulunov A, McCuaig C, Frieden IJ, et al., Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol 2011; 28: 94-98.
19. Ademola JI, Chow CA, Wester RC, et al., Metabolism of propranolol during percutaneous absorption in human skin. J Pharm Sci 1993; 82: 767-770.
20. Mishra D, Garg M, Dubey V, et al., Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sc 2007; 96: 145-155.
21. Kobayashi I, Hosaka K, Saeki Y, et al., Skin toxicity of propranolol in guinea pigs. J Toxicol Sci 1999; 24: 103-112.
22. Kobayashi I, Hosaka K, Ueno T, et al., Relationship between the amount of propranolol permeating through the stratum corneum of guinea pig skin after application of propranolol adhesive patches and skin irritation. Biol Pharm Bull 1996; 19: 839-844.
23. Ahad A, Aqil M, Kohli K, et al., Interactions between novel terpenes and main componentes of rat and human skin:mechanistic view of transdermal delivery of propranolol hydrochlorid. Curr Drug Deliv 2011; 8: 208-212.